Apolipoprotein e isoforms and lipoprotein metabolism

IUBMB Life

Volumn 66, Issue 9, 2014, Pages 616-623

  Phillips, Michael C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

apolipoprotein E; atherosclerosis; cholesterol; high density lipoprotein; lipoprotein metabolism; low density lipoprotein receptor; triglyceride; very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ISOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; LIPOPROTEIN; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; CARBOXY TERMINAL SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HYPERLIPOPROTEINEMIA; LIPOLYSIS; LIPOPROTEIN METABOLISM; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; CHEMICAL STRUCTURE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENETICS; METABOLISM;

AMINO ACID SUBSTITUTION; APOLIPOPROTEINS E; HUMANS; LIPID METABOLISM DISORDERS; LIPOPROTEINS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN ISOFORMS;

EID: 84924405717     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1314     Document Type: Review

References (59)

1. Davignon, J., Cohn, J. S., Mabile, L., and, Bernier, L., (1999) Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin. Chim. Acta 286, 115-143.
2. Mahley, R. W., Weisgraber, K. H., and, Huang, Y., (2009) Apolipoprotein E: Structure determines function-from atherosclerosis to Alzheimer's disease to AIDS. J. Lipid Res. 50, S183-S188.
3. Getz, G. S., and, Reardon, C. A., (2009) Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J. Lipid Res. 50, S156-S161.
4. Davignon, J., Gregg, R. E., and, Sing, C. F., (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21.
5. Segrest, J. P., Jones, M. K., De Loof, H., Brouillette, C. G., Venkatachalapathi, Y. V., and, Anantharamaiah, G. M., (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33, 141-166.
6. Weisgraber, K. H., (1994) Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45, 249-302.
7. Hatters, D. M., Peters-Libeu, C. A., and, Weisgraber, K. H., (2006) Apolipoprotein E structure: insights into function. Trends Biochem.Sci. 31, 445-454.
8. Hauser, P. S., Narayanaswami, V., and, Ryan, R. O., (2011) Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res 50, 62-74.
9. Chen, J., Li, Q., and, Wang, J., (2011) Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc. Natl. Acad. Sci. USA 108, 14813-14818.
10. Morrow, J. A., Arnold, K. S., Dong, J., Balestra, M. E., Innerarity, T. L., et al. (2000) Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor. J. Biol. Chem. 275, 2576-2580.
11. Libeu, C. P., Lund-Katz, S., Phillips, M. C., Wehrli, S., Hernaiz, M. J., et al. (2001) New insights into the heparin sulfate proteoglycan-binding activity in apolipoprotein E. J. Biol. Chem. 276, 39138-39144.
12. Zaiou, M., Arnold, K. S., Newhouse, Y. M., Innerarity, T. L., Weisgraber, K. H., et al. (2000) Apolipoprotein E-low density lipoprotein receptor interaction: influences of basic residue and amphipathic alpha-helix organization in the ligand. J. Lipid Res. 41, 1087-1095.
13. Futamura, M., Dhanasekaran, P., Handa, T., Phillips, M. C., Lund-Katz, S., et al. (2005) Two-step mechanism of binding of apolipoprotein E to heparin. J. Biol. Chem. 280, 5414-5422.
14. Westerlund, J. A., and, Weisgraber, K. H., (1993) Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268, 15745-15750.
15. Sakamoto, T., Tanaka, M., Vedhachalam, C., Nickel, M., Nguyen, D., et al. (2008) Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. Biochemistry 47, 2968-2977.
16. Nguyen, D., Dhanasekaran, P., Nickel, M., Nakatani, R., Saito, H., et al. (2010) Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry 49, 10881-10889.
17. Garai, K., Baban, B., and, Frieden, C., (2011) Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles. Biochemistry 50, 2550-2558.
18. Saito, H., Dhanasekaran, P., Nguyen, D., Holvoet, P., Lund-Katz, S., et al. (2003) Domain structure and lipid interaction in human apolipoproteins A-I and E: a general model. J. Biol. Chem. 278, 23227-23232.
19. Saito, H., Lund-Katz, S., and, Phillips, M. C., (2004) Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog. Lipid Res. 43, 350-380.
20. Nguyen, D., Dhanasekaran, P., Phillips, M. C., and, Lund-Katz, S., (2009) Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry 48, 3025-3032.
21. Lu, B., Morrow, J. A., and, Weisgraber, K. H., (2000) Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid. J. Biol. Chem. 275, 20775-20781.
22. Fisher, C. A., Narayanaswami, V., and, Ryan, R. O., (2000) The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E. J. Biol. Chem. 275, 33601-33606.
23. Narayanaswami, V., Szeto, S. S., and, Ryan, R. O., (2001) Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3. J. Biol. Chem. 276, 37853-37860.
24. Narayanaswami, V., Maiorano, J. N., Dhanasekaran, P., Ryan, R. O., Phillips, M. C., et al. (2004) Helix orientation of the functional domains in apolipoprotein E in discoidal high density lipoprotein particles. J. Biol. Chem. 279, 14273-14279.
25. Schneeweis, L. A., Koppaka, V., Lund-Katz, S., Phillips, M. C., and, Axelsen, P. H., (2005) Structural analysis of lipoprotein E particles. Biochemistry 44, 12525-12534.
26. Peters-Libeu, C. A., Newhouse, Y., Hall, S. C., Witkowska, H. E., and, Weisgraber, K. H., (2007) Apolipoprotein E dipalmitoylphosphatidylcholine particles are ellipsoidal in solution. J.Lipid Res. 48, 1035-1044.
27. Narayanaswami, V., and, Ryan, R. O., (2000) Molecular basis of exchangeable apolipoprotein function. Biochim. Biophys. Acta 1483, 15-36.
28. Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K., Lund-Katz, S., et al. (2001) Lipid binding-induced conformational change in human apolipoprotein E. J. Biol. Chem. 276, 40949-40954.
29. Lund-Katz, S., Zaiou, M., Wehrli, S., Dhanasekaran, P., Baldwin, F., et al. (2000) Effects of lipid interaction on the lysine microenvironments in apolipoprotein E. J. Biol. Chem. 275, 34459-34464.
30. Gupta, V., Narayanaswami, V., Budamagunta, M. S., Yamamato, T., Voss, J. C., et al. (2006) Lipid-induced extension of apolipoprotein E helix 4 correlates with low density lipoprotein receptor binding ability. J. Biol. Chem. 281, 39294-39299.
31. Bradley, W. A., Hwang, S. L., Karlin, J. B., Lin, A. H., Prasad, S. C., et al. (1984) Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J. Biol. Chem. 259, 14728-14735.
32. Mahley, R. W., and, Ji, S. Z., (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid. Res. 40, 1-16.
33. Mahley, R. W., Huang, Y., and, Rall, S. C., (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J. Lipid Res. 40, 1933-1949.
34. Sundaram, M., and, Yao, Z., (2012) Intrahepatic role of exchangeable apolipoproteins in lipoprotein assembly and secretion. Arterioscler. Thromb. Vasc. Biol. 32, 1073-1078.
35. Huang, Y., Liu, X. Q., Rall, S. C., Jr., Taylor, J. M., von Eckardstein, A., et al. (1998) Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 273, 26388-26393.
36. Heeren, J., Beisiegel, U., and, Grewal, T., (2006) Apolipoprotein E recycling. Implications for dyslipidemia and atherosclerosis. Arterioscler.Thromb.Vasc.Biol. 26, 442-448.
37. Bellosta, S., Mahley, R. W., Sanan, D. A., Murata, J., Newland, D. L., et al. (1995) Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96, 2170-2179.
38. Weisgraber, K. H., Innerarity, T. L., and, Mahley, R. W., (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257, 2518-2521.
39. Dong, L. M., Parkin, S., Trakhanov, S. D., Rupp, B., Simmons, T., et al. (1996) Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat. Struct. Biol. 3, 718-722.
40. Dong, L. M., Innerarity, T. L., Arnold, K. S., Newhouse, Y. M., and, Weisgraber, K. H., (1998) The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity. J. Lipid Res. 39, 1173-1180.
41. Mann, W. A., Meyer, N., Weber, W., Meyer, S., Greten, H., et al. (1995) Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia. J. Lipid Res. 36, 517-525.
42. Steinmetz, A., Jakobs, C., Motzny, S., and, Kaffarnik, H., (1989) Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis 9, 405-411.
43. Weisgraber, K. H., (1990) Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31, 1503-1511.
44. Morrow, J. A., Segall, M. L., Lund-Katz, S., Phillips, M. C., Knapp, M., et al. (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39, 11657-11666.
45. Morrow, J. A., Hatters, D. M., Lu, B., Hocht, P., Oberg, K. A., et al. (2002) Apolipoprotein E4 forms a molten globule. J. Biol. Chem. 277, 50380-50385.
46. Dong, L. M., and, Weisgraber, K. H., (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271, 19053-19057.
47. Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., et al. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269, 22358-22365.
48. Frieden, C., and, Garai, K., (2013) Concerning the structure of apoE. Protein Sci. 22, 1820-1825.
49. Hatters, D. M., Budamagunta, M. S., Voss, J. C., and, Weisgraber, K. H., (2005) Modulation of apolipoprotein E structure by domain interaction. Differences in lipid-bound and lipid-free forms. J. Biol. Chem. 280, 34288-34295.
50. Drury, J., and, Narayanaswami, V., (2005) Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence. J. Biol. Chem. 280, 14605-14610.
51. Nguyen, D., Dhanasekaran, P., Nickel, M., Mizuguchi, C., Watanabe, M., et al. (2014) Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E. Biochemistry 53, 4025-4033.
52. Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., Phillips, M. C., et al. (2003) Effects of polymorphism on the lipid interaction of human apolipoprotein E. J. Biol. Chem. 278, 40723-40729.
53. Knouff, C., Hinsdale, M. E., Mezdour, H., Altenburg, M. K., Watanabe, M., et al. (1999) Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin.Invest. 103, 1579-1586.
54. Pendse, A. A., Arbones-Mainar, J. M., Johnson, L. A., Altenburg, M., and, Maeda, N., (2009) ApoE knock-out and knock-in mice: Atherosclerosis, metabolic syndrome, and beyond. J. Lipid Res. 50, S178-S182.
55. Kitajima, K., Marchadier, D. H., Miller, G. C., Gao, G. P., Wilson, J. M., et al. (2006) Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8. Arterioscler. Thromb. Vasc. Biol. 26, 1852-1857.
56. Zannis, V. I., Chroni, A., Kypreos, K. E., Kan, H. Y., Cesar, T. B., et al. (2004) Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. Curr. Opin. Lipidol. 15, 151-166.
57. Li, H., Dhanasekaran, P., Alexander, E. T., Rader, D. J., Phillips, M. C., et al. (2013) Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 33, 687-693.
58. Weisgraber, K. H., Mahley, R. W., Kowal, R. C., Herz, J., Goldstein, J. L., et al. (1990) Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265, 22453-22459.
59. Rensen, P. C. N., and, Van Berkel, T. J. C., (1996) Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J. Biol. Chem. 271, 14791-14799.